Literature DB >> 3982638

Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study.

J J Askenasy, M D Yahr.   

Abstract

In a previous study, the sleep pattern in Parkinson's disease patients was found to be altered. The disturbance consisted of a "light fragmented sleep pattern" with increased muscle activity. Using a combined polysomnographic and electromyographic recording technique, we found that a reversal of the light fragmented sleep pattern and normalization of muscle activity during sleep occurred after clinical improvement with dopaminergic treatment. The effect of dopaminergic treatment on sleep disturbance was analyzed. There is an intimate relationship between sleep pattern and the normalization of sleep muscle activity produced by dopaminergic agents.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3982638     DOI: 10.1212/wnl.35.4.527

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 2.  Excessive daytime sleepiness and unintended sleep episodes associated with Parkinson's disease.

Authors:  Fatai Salawu; Abdulfatai Olokoba
Journal:  Oman Med J       Date:  2015-01

3.  Changes in nocturnal sleep in Huntington's and Parkinson's disease.

Authors:  W Emser; M Brenner; T Stober; K Schimrigk
Journal:  J Neurol       Date:  1988-01       Impact factor: 4.849

4.  Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa.

Authors:  A L Leeman; C J O'Neill; P W Nicholson; A A Deshmukh; M J Denham; J P Royston; R J Dobbs; S M Dobbs
Journal:  Br J Clin Pharmacol       Date:  1987-11       Impact factor: 4.335

Review 5.  A risk-benefit assessment of drugs used in the management of Parkinson's disease.

Authors:  I Y Bodagh; D R Robertson
Journal:  Drug Saf       Date:  1994-08       Impact factor: 5.606

6.  Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep.

Authors:  J J Askenasy; M D Yahr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

Review 7.  Drug-induced sleep disturbances. Focus on nonpsychotropic medications.

Authors:  M Novak; C M Shapiro
Journal:  Drug Saf       Date:  1997-02       Impact factor: 5.606

8.  Nocturnal sleep in multisystem atrophy with autonomic failure: polygraphic findings in ten patients.

Authors:  R Manni; R Morini; E Martignoni; C Pacchetti; G Micieli; A Tartara
Journal:  J Neurol       Date:  1993       Impact factor: 4.849

9.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  Are periodic movements in sleep a basal ganglia dysfunction?

Authors:  J J Askenasy; E D Weitzman; M D Yahr
Journal:  J Neural Transm       Date:  1987       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.